Ocular manifestations in autosomal dominant retinitis pigmentosa with a Lys-296-Glu rhodopsin mutation at the retinal binding site

11Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

A lysine to glutamic acid substitution at codon 2% in the rhodopsin gene has been reported in a family with autosomal dominant retinitis pigmentosa. This mutation is of particular functional interest as this lysine molecule is the binding site of 11-cis-retinal. The clinical features of a family with this mutation have not been reported previously. We examined 14 patients with autosomal dominant retinitis pigmentosa and a lysine-296-glutamic acid rhodopsin mutation. Four had detailed psychophysical and electrophysiological testing. Most affected subjects had severe disease with poor night vision from early life, and marked reduction of visual acuity and visual field by their early forties. Psychophysical testing showed no demonstrable rod function and severely reduced cone function in all patients tested.

Cite

CITATION STYLE

APA

Owens, S. L., Fitzke, F. W., Inglehearn, C. F., Jay, M., Keen, T. J., Arden, G. B., … Bird, A. C. (1994). Ocular manifestations in autosomal dominant retinitis pigmentosa with a Lys-296-Glu rhodopsin mutation at the retinal binding site. British Journal of Ophthalmology, 78(5), 353–358. https://doi.org/10.1136/bjo.78.5.353

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free